Dealbreaker on MSN
Function Health Hits $2.5B Valuation With $298M Series B
The Austin-based startup offers subscribers access to more than 160 lab tests, as well as imaging.
For decades, the health system has prioritized outdated processes and profits, with people only visiting primary care doctors for routine annual check-ups or on a reactive basis after experiencing ...
Novel biomarker tests have met or exceeded the performance of common lab tests for diagnosing nonalcoholic steatohepatitis (NASH, now known as metabolic dysfunction-associated steatohepatitis or MASH) ...
No single blood test can diagnose liver cancer, but liver cancer blood tests can detect signs of liver dysfunction. Depending on a person’s signs and symptoms, a doctor may recommend further testing, ...
LabCorp has signed a new, five-year agreement to license a blood test from Genfit designed to identify patients with risky cases of nonalcoholic steatohepatitis, also known as NASH. NASH has been a ...
Research from the Medical University of South Carolina's Digestive Disease Research Core Center suggests that physicians can fail to diagnose alcoholic cirrhosis if they rely solely on laboratory test ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results